X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (195) 195
index medicus (151) 151
hyperphosphatemia (119) 119
male (110) 110
urology & nephrology (105) 105
female (82) 82
animals (71) 71
hyperphosphatemia - physiopathology (66) 66
middle aged (58) 58
chronic kidney-disease (54) 54
hyperphosphatemia - etiology (52) 52
renal insufficiency, chronic - physiopathology (51) 51
adult (47) 47
chronic kidney disease (47) 47
aged (45) 45
vascular calcification (44) 44
risk factors (43) 43
nephrology (42) 42
phosphate (42) 42
hemodialysis-patients (41) 41
phosphates - blood (41) 41
kidney failure, chronic - physiopathology (39) 39
calcium (37) 37
phosphates (35) 35
stage renal-disease (34) 34
parathyroid-hormone (33) 33
kidney - physiopathology (32) 32
phosphates - metabolism (31) 31
mortality (30) 30
phosphorus (30) 30
kidney failure, chronic - complications (28) 28
renal dialysis (27) 27
renal insufficiency, chronic - complications (26) 26
secondary hyperparathyroidism (26) 26
chronic kidney failure (25) 25
hyperphosphatemia - blood (25) 25
rats (25) 25
calcification (24) 24
glomerular filtration rate (24) 24
hyperphosphatemia - complications (24) 24
hyperphosphatemia - drug therapy (24) 24
kidney - metabolism (24) 24
kidney failure, chronic - therapy (24) 24
calcium - blood (23) 23
biomarkers - blood (22) 22
disease progression (22) 22
fgf23 (22) 22
parathyroid hormone (22) 22
parathyroid hormone - blood (22) 22
chronic-renal-failure (21) 21
coronary-artery calcification (21) 21
endocrinology & metabolism (21) 21
hemodialysis (21) 21
homeostasis (21) 21
phosphorus - blood (21) 21
sevelamer (21) 21
disease models, animal (20) 20
fibroblast growth factors - blood (20) 20
mice (20) 20
time factors (20) 20
treatment outcome (20) 20
cardiovascular diseases - etiology (19) 19
dialysis (19) 19
medicine & public health (19) 19
calcinosis - etiology (18) 18
cardiovascular-disease (18) 18
dialysis patients (18) 18
hyperparathyroidism, secondary - etiology (18) 18
kidney diseases - physiopathology (18) 18
left-ventricular hypertrophy (18) 18
renal insufficiency, chronic - blood (18) 18
serum phosphorus (18) 18
vitamin-d (18) 18
growth-factor 23 (17) 17
hyperphosphatemia - metabolism (17) 17
mineral metabolism (17) 17
chelating agents - therapeutic use (16) 16
fibroblast growth factors - metabolism (16) 16
kidney diseases (16) 16
renal insufficiency, chronic - therapy (16) 16
transplantation (16) 16
vitamin d (16) 16
article (15) 15
calcinosis - physiopathology (15) 15
calcium - metabolism (15) 15
pediatrics (15) 15
renal insufficiency, chronic - metabolism (15) 15
urologic and male genital diseases (15) 15
cardiovascular disease (14) 14
diet (14) 14
fibroblast growth factor-23 (14) 14
hyperparathyroidism, secondary - physiopathology (14) 14
hyperphosphatemia - therapy (14) 14
kidney failure, chronic - metabolism (14) 14
klotho (14) 14
medicine, general & internal (14) 14
physiological aspects (14) 14
rats, sprague-dawley (14) 14
severity of illness index (14) 14
abridged index medicus (13) 13
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Heart Journal, ISSN 0195-668X, 06/2014, Volume 35, Issue 23, pp. 1515 - 1525
Vascular calcifications (VCs) are actively regulated biological processes associated with crystallization of hydroxyapatite in the extracellular matrix and in... 
Vascular molecular biology and genetics | CALCIUM-PHOSPHATE DEPOSITION | ATHEROSCLEROTIC LESIONS | FETUIN-A LEVELS | NONINVASIVE EVALUATION | CARDIAC & CARDIOVASCULAR SYSTEMS | PSEUDOXANTHOMA ELASTICUM | EXTRACELLULAR CALCIUM | MONCKEBERGS SCLEROSIS | Vascular function | ARTERY CALCIFICATION | SMOOTH-MUSCLE-CELLS | CHRONIC KIDNEY-DISEASE | Vascular calcifications | Monckeberg's media sclerosis | Tunica Media - pathology | Prognosis | Monckeberg Medial Calcific Sclerosis - physiopathology | Humans | Tunica Intima - physiopathology | Male | Monckeberg Medial Calcific Sclerosis - therapy | Diabetic Angiopathies - physiopathology | Monckeberg Medial Calcific Sclerosis - pathology | Diabetic Angiopathies - pathology | Vascular Calcification - physiopathology | Adult | Female | Biomarkers - metabolism | Arteriosclerosis - physiopathology | Terminology as Topic | Vascular Calcification - pathology | Phosphates - physiology | Renal Insufficiency, Chronic - physiopathology | Diabetes Mellitus, Type 2 - physiopathology | Tunica Intima - pathology | Calcium-Binding Proteins - physiology | Diabetes Mellitus, Type 2 - pathology | Vascular Calcification - therapy | Hyperphosphatemia - physiopathology | Tunica Media - physiopathology | Arteriosclerosis - pathology | Index Medicus | Life Sciences | Human health and pathology | Cardiology and cardiovascular system | Mönckeberg's media sclerosis | Reviews
Journal Article
Critical Care Medicine, ISSN 0090-3493, 06/2010, Volume 38 Suppl, Identification and Prevention of Common Adverse Drug Events in the Intensive Care Unit, Issue 6, pp. S253 - S264
Electrolyte imbalances are common in critically ill patients. Although multiple disease states typically encountered in the intensive care unit may be... 
Hypercalcemia | Critical illness | Hyperkalemia | Hyponatremia | Hypernatremia | Hypermagnesemia | Hyperphosphatemia | Hypokalemia | Hypophosphatemia | Water-electrolyte imbalance | Hypocalcemia | Hypomagnesemia | HOSPITALIZED-PATIENTS | hypernatremia | critical illness | hyperkalemia | AMPHOTERICIN-B NEPHROTOXICITY | DRUG-INDUCED HYPERKALEMIA | CONVERTING ENZYME-INHIBITORS | hypercalcemia | CATION-EXCHANGE RESIN | hypokalemia | hypocalcemia | hyperphosphatemia | hyponatremia | HEPARIN-INDUCED HYPERKALEMIA | TRIMETHOPRIM-SULFAMETHOXAZOLE THERAPY | hypomagnesemia | hypermagnesemia | RENAL TUBULAR-ACIDOSIS | NEPHROGENIC DIABETES-INSIPIDUS | hypophosphatemia | CRITICALLY-ILL PATIENTS | water-electrolyte imbalance | CRITICAL CARE MEDICINE | Critical Care - methods | Hypernatremia - physiopathology | Hyponatremia - chemically induced | Hypocalcemia - physiopathology | Magnesium Deficiency - physiopathology | United States | Humans | Hypocalcemia - chemically induced | Magnesium Deficiency - chemically induced | Hypokalemia - chemically induced | Hyponatremia - physiopathology | Hypophosphatemia - chemically induced | Hypokalemia - physiopathology | Intensive Care Units | Hyperphosphatemia - chemically induced | Water-Electrolyte Imbalance - chemically induced | Hyperkalemia - physiopathology | Drug-Related Side Effects and Adverse Reactions - etiology | Magnesium - metabolism | Hypercalcemia - chemically induced | Hypernatremia - chemically induced | Hypercalcemia - physiopathology | Hypophosphatemia - physiopathology | Water-Electrolyte Imbalance - physiopathology | Hyperkalemia - chemically induced | Hyperphosphatemia - physiopathology | Drug-Related Side Effects and Adverse Reactions - physiopathology | Index Medicus | Abridged Index Medicus
Journal Article
Kidney International, ISSN 0085-2538, 12/2003, Volume 64, Issue 6, pp. 2272 - 2279
Journal Article
Kidney International, ISSN 0085-2538, 06/2011, Volume 79, Issue 12, pp. 1370 - 1378
Journal Article
Primary Care - Clinics in Office Practice, ISSN 0095-4543, 06/2008, Volume 35, Issue 2, pp. 215 - 237
Journal Article
Pediatric Nephrology, ISSN 0931-041X, 4/2013, Volume 28, Issue 4, pp. 583 - 593
Journal Article
American Journal of Physiology - Renal Physiology, ISSN 0363-6127, 2015, Volume 309, Issue 11, pp. F967 - F979
Vascular calcification (VC) is a critical complication in patients with chronic kidney disease (CKD). The effects of spironolactone (SPL), a mineralocorticoid... 
Hyperphosphatemia | Vascular calcification | Chronic kidney disease | Spironolactone | Mineralocorticoid receptor | chronic kidney disease | OXIDATIVE STRESS | PHYSIOLOGY | vascular calcification | HEART-FAILURE | CELL-PROLIFERATION | SERUM | mineralocorticoid receptor | spironolactone | PHOSPHATE | hyperphosphatemia | INFLAMMATION | REGULATED KINASE 1 | ALDOSTERONE BLOCKADE | UROLOGY & NEPHROLOGY | CHRONIC KIDNEY-DISEASE | CHRONIC-RENAL-FAILURE | Kidney - pathology | Apoptosis - drug effects | Humans | Uremia - physiopathology | Uremia - drug therapy | Male | Aorta, Abdominal - drug effects | Hyperphosphatemia - blood | Kidney - metabolism | Time Factors | Tunica Media - metabolism | Mineralocorticoid Receptor Antagonists - pharmacology | Aortic Diseases - prevention & control | Disease Models, Animal | Kidney - drug effects | Biomarkers - blood | Vascular Calcification - pathology | Rats, Sprague-Dawley | Renal Insufficiency, Chronic - physiopathology | Disease Progression | Signal Transduction - drug effects | Hyperphosphatemia - drug therapy | Renal Insufficiency, Chronic - chemically induced | Tunica Media - pathology | Tunica Media - drug effects | Receptors, Mineralocorticoid - metabolism | Aortic Diseases - blood | Aortic Diseases - chemically induced | Renal Insufficiency, Chronic - drug therapy | Dose-Response Relationship, Drug | Receptors, Mineralocorticoid - drug effects | Uremia - chemically induced | Spironolactone - pharmacology | Uremia - pathology | Vascular Calcification - physiopathology | Aorta, Abdominal - pathology | Aorta, Abdominal - metabolism | Kidney - physiopathology | Aortic Diseases - pathology | Osteogenesis - drug effects | Vascular Calcification - blood | Adenine | Vascular Calcification - prevention & control | Renal Insufficiency, Chronic - pathology | Renal Insufficiency, Chronic - blood | Aortic Diseases - physiopathology | Animals | Uremia - blood | Vascular Calcification - chemically induced | Renin-Angiotensin System - drug effects | Antiandrogens | Calcification | Corticosteroids | Chronic kidney failure | Steroids | Cellular signal transduction | Observations | Health aspects
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 02/2010, Volume 30, Issue 2, pp. 333 - 339
Journal Article